Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page footer/update indicator was updated from revision v3.5.2 to v3.5.3, reflecting a site software version change rather than a change to the clinical trial record.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision history now includes v3.5.0 and removes v3.4.3; this change updates revision metadata only.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Revision: v3.4.3 to the history and removed Revision: v3.4.2.SummaryDifference0.1%

- Check74 days agoChange DetectedThe history now shows a new site revision (v3.4.2) replacing v3.4.1; there are no substantive updates to study records or page content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry (v3.4.1) was added and the previous revision (v3.4.0) removed. This is a minor metadata update to the page history with no impact on study content or data.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.